Your First 12 Weeks of Medical Weight Loss: What to Expect

Know what to expect in your first 12 weeks: treatment adjustment, practical food and activity habits, and Heracles’ ongoing clinical check-ins.

Table of contents

The first 12 weeks are about getting comfortable with treatment and building routines you can keep. Appetite, eating habits and weight may change as you learn what works for you.

Heracles supports that process with doctor-led weight care, monthly clinical check-ins and dose reviews. Use this guide to understand each stage and what to raise with your team.

At a glance

  • Follow your prescribed treatment schedule and ask before changing a dose.
  • Keep food, fluids and manageable activity part of your routine.
  • Review progress and side effects together; seek help promptly for severe or persistent symptoms.

Before week 1: establish your baseline

A good starting review gives you something meaningful to compare with later. Depending on your health and the treatment plan, it may include:

  • current weight and height;
  • waist circumference and waist-to-height ratio;
  • blood pressure;
  • relevant symptoms and existing conditions;
  • current prescription, over-the-counter and non-prescribed products;
  • usual meals, protein sources, fluids and alcohol;
  • activity, strength training, mobility and injury history;
  • sleep, snoring or suspected sleep apnoea;
  • previous weight-loss attempts and what made them difficult;
  • blood tests or other investigations where they answer a clinical question.

NICE recommends using waist-to-height ratio alongside BMI in adults with a BMI below 35 kg/m² and identifying conditions that may affect, or be affected by, weight. NICE assessment guidance

Agree what success means

Choose outcomes that relate to health and daily life. Depending on the person, these might include improved blood pressure, less breathlessness, better mobility, a smaller waist, improved glucose control, better sleep or the ability to train consistently.

Your progress is individual. Review changes in health and daily life alongside weight, rather than aiming for a promised weekly loss. ASA/CAP weight-control guidance

Know how to get help

Before starting, confirm:

  • how to contact the clinical team;
  • what to do outside normal hours;
  • where your treatment instructions are stored;
  • which symptoms should prompt an urgent call;
  • the date or trigger for your first review.

Weeks 1–4: adjustment and observation

The first month should be treated as an adjustment phase, particularly when a prescription treatment is being introduced. The absence of an immediate dramatic change is not a reason to alter the plan yourself.

Appetite and meal size may change

Some weight-management medicines alter hunger, fullness or digestion. You may feel satisfied by smaller portions or find that heavy meals are less comfortable. Other approaches may change meal structure without producing a strong appetite effect.

The practical aim is regular, nutritionally useful intake. A reduced appetite can make it easy to under-eat protein, fibre, fluids, vitamins and minerals. That is not the same as a better diet.

Useful early habits include:

  • planning smaller, balanced meals rather than waiting until you feel extremely hungry;
  • including a source of protein in each main meal;
  • choosing nutrient-dense foods when appetite is limited;
  • drinking regularly rather than trying to catch up late in the day;
  • reducing large, rich or very fatty meals if they worsen symptoms;
  • limiting alcohol, especially while you are learning how treatment affects you.

The 2025 multi-society clinical advisory on GLP-1 therapy highlights baseline nutrition assessment, gastrointestinal side-effect management, nutrient adequacy, resistance training and appropriate diet as priorities. Joint nutrition advisory

Common digestive symptoms need monitoring

Nausea, vomiting, diarrhoea and other gastrointestinal symptoms are reported with GLP-1 medicines. Many episodes are mild or short-lived, but vomiting and diarrhoea can cause serious dehydration. MHRA patient guidance

Contact your prescribing team if symptoms are persistent, worsening, stopping you from drinking, or making it difficult to meet basic nutritional needs. Do not take another person's anti-sickness medicine or change your prescribed dose without advice.

Keep activity achievable

The first month is not the time to punish yourself with a sudden, extreme training plan. If you are currently inactive, begin with activity you can recover from and repeat. Walking, short movement breaks and basic resistance work may be more useful than an unsustainable burst of high-volume exercise.

The UK Chief Medical Officers advise that any activity is better than none and that adults should build or maintain strength in the major muscle groups on at least two days each week. UK physical activity guidelines

Weeks 5–8: build a repeatable system

By the second month, the focus should move from novelty to consistency. Review what is actually happening rather than what the plan assumed would happen.

Review tolerance before changing treatment

If your treatment has a planned dose-escalation schedule, that schedule is not permission to increase regardless of symptoms. Follow the instructions from your prescriber and raise concerns before changing dose.

A clinical review may consider:

  • the frequency and severity of side effects;
  • hydration and bowel habit;
  • appetite and whether food intake has become too limited;
  • adherence and any missed doses;
  • other medicines and whether monitoring needs have changed;
  • weight and waist trend;
  • blood pressure or other markers where relevant;
  • strength, fatigue, recovery and daily function;
  • mood, eating behaviour and relationship with food.

NICE recommends regular review of the effect of weight-management medicines while reinforcing behavioural advice and adherence. NICE medicines guidance

Make the nutrition plan more specific

“Eat better” is not an operating plan. By weeks 5–8, identify the meals and situations most likely to cause difficulty.

Questions worth answering include:

  • Which breakfasts reliably provide protein and are still comfortable?
  • What can you eat on a busy workday?
  • What happens when you miss lunch?
  • Which foods worsen nausea, reflux, constipation or diarrhoea?
  • Are fruit, vegetables, whole grains or other fibre sources still present?
  • Are you drinking enough to replace losses when symptoms occur?
  • Is alcohol displacing food or worsening side effects?

If appetite is very low, a registered dietitian or appropriately qualified nutrition professional can help make a smaller amount of food work harder nutritionally.

Progress resistance training gradually

If clinically appropriate, aim to develop a simple full-body pattern rather than collecting random exercises. A starting plan might include a squat or sit-to-stand pattern, a push, a pull, a hip-hinge pattern and a loaded carry or trunk exercise.

Progress means doing slightly more over time while maintaining technique and recovery. It does not mean increasing every variable every session. Pain, dizziness, marked weakness or poor recovery are reasons to reassess.

Weeks 9–12: judge the pathway, not one weigh-in

At the end of 12 weeks, review whether the plan is safe, tolerable, clinically useful and sustainable enough to continue. An online average is not an individual treatment target.

Review the trend

Use several data points where possible:

  • weight trend measured under similar conditions;
  • waist measurement;
  • blood pressure or relevant laboratory markers;
  • appetite and food quality;
  • side effects;
  • strength, mobility and exercise tolerance;
  • sleep and daytime energy;
  • ability to follow the plan during normal life;
  • the cost and burden of treatment.

Different licensed medicines have different review and stopping criteria. Those decisions should use the relevant product information, NICE guidance and the clinician's assessment—not a generic rule copied from another treatment.

Plan the next phase

The next step might be to continue, adjust support, review treatment, investigate another health issue, refer to a specialist service, or plan maintenance. If a medicine is stopped, NICE recommends support to help maintain weight loss. NICE medicines guidance

Maintenance should not begin on the day treatment ends. The routines that make maintenance possible—repeatable meals, resistance training, activity, sleep, self-monitoring and a response plan for regain—should be developed during treatment.

Keep your review notes simple

Keep a brief note of your weight trend, symptoms, eating, hydration and energy. Check waist and strength periodically if useful. Bring changes and questions to your review; detailed food logs are unnecessary if they become burdensome or distressing.

When to seek urgent help

Follow the emergency advice supplied with your treatment. For GLP-1 medicines, MHRA guidance highlights several symptoms that need prompt action.

Seek urgent medical help for severe, persistent abdominal pain that may radiate to the back, as this can be a symptom of acute pancreatitis. Sudden blindness or rapid deterioration in eyesight while using semaglutide also requires urgent assessment. Severe dehydration, collapse, breathing difficulty, facial or throat swelling, or another suspected serious reaction require urgent care. MHRA patient guidance

If you are unsure whether a symptom is urgent, contact NHS 111 or the emergency service appropriate to the severity of the situation.

Situations that need specific advice

Contact your clinical team before changing treatment if:

  • you are due to have surgery or a procedure with anaesthesia or deep sedation;
  • you have persistent vomiting or diarrhoea;
  • you cannot maintain fluid or food intake;
  • you develop new severe abdominal symptoms;
  • another clinician changes medicines that affect blood glucose, blood pressure or hydration;
  • you want to switch between products;
  • you are considering stopping treatment;
  • your eating has become highly restrictive or distressing.

The MHRA advises patients taking GLP-1 medicines to tell the surgical and anaesthetic team before a procedure because delayed stomach emptying can affect aspiration risk. Do not stop prescribed treatment without discussing it with your doctor. MHRA patient guidance

Start with support that continues

Heracles’ monthly check-ins give you a regular opportunity to review progress, side effects and treatment decisions. Bring questions about appetite, eating, energy or activity so the plan reflects your experience.

See how your assessment works and take the next step when you are ready.

More frequently asked questions

When should I stop treatment?

That depends on the specific treatment, its licensed guidance, your response, adverse effects and clinical circumstances. Discuss it with your prescriber and make a maintenance plan; do not apply another product's stopping rule to your own treatment.

Start your weight-loss journey with a clear clinical plan. Start your Heracles assessment.